Canaccord Genuity Maintains Hold on Hologic, Lowers Price Target to $50

Canaccord Genuity maintains Hologic (NASDAQ:HOLX) with a Hold and lowers the price target from $52 to $50.

Benzinga · 11/11/2019 13:27

Canaccord Genuity maintains Hologic (NASDAQ:HOLX) with a Hold and lowers the price target from $52 to $50.